Fortress Biotech Inc (FBIO) Stock Price, Quote & News

Company Profile

Fortress Biotech, Inc., a biopharmaceutical company, engages in the development and commercialization of biopharmaceutical products. The company markets dermatology products, including Emrosi, a minocycline hydrochloride extended-release capsule for the treatment of rosacea; Qbrexza a medicated cloth towelette for primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug for severe recalcitrant nodular acne; Amzeeq, a topical formulation of minocycline for inflammatory lesions of non-n...

Industry: Biotechnology

Sector: Healthcare

Phone: 781 652 4500

Website: www.fortressbiotech.com

Address:

1111 Kane Concourse, Suite 301, Bay Harbor Islands, United States

LiquidThetaLEAPS Oct. 25 at 4:28 PM

LiquidTheta® LEAPS LIVE Actionable Alert Asset: $FBIO Current Share Price: $2.51 Contracts: $FBIO April 17, 2026 $5 Calls Scale in: $0.19- $0.23 Scale out: $0.30-$0.38 Can Easily Capture: 60% ROI Blended DTE: 174 Days | Join Elites here: https://liquidtheta.com

0 · Reply

UnicornProfits Oct. 24 at 8:34 PM

What is happening to ticker CMCT right now?! CMCT is breaking out like crazy.. Are they pumping up ticker CMCT for 300% today!? Its insane what's going on in this market.. Looks like all eyes are moving to CMCT now.. Watching: $ABCL $FBIO $SNDX $TGTX bios

1 · Reply

makrodimutross Oct. 24 at 4:52 PM

$FBIO $FBIOP this is excellent news for Helocyte. And P2 data is due any moment now from the 30 / 60 1:2 HIV study. 96 week follow up after complete enrolment was several weeks ago now.

0 · Reply

LiquidThetaLEAPS Oct. 24 at 2:08 AM

LiquidTheta® LEAPS LIVE Actionable Alert Asset: $FBIO Current Share Price: $2.56 Contracts: $FBIO April 17, 2026 $5 Calls Scale in: $0.25- $0.30 Scale out: $0.39-$0.50 Can Easily Capture: 60% ROI Blended DTE: 176 Days | Join Elites here: https://liquidtheta.com/options

0 · Reply

braves1983 Oct. 23 at 7:01 PM

$FBIO when the fuck is this getting back to $3 so I can get the fuck out. God damn. All this fucking waiting for years here and we got fucked again

2 · Reply

Sawnchey Oct. 23 at 4:48 PM

$FBIO $FBIOP A miss for Moderna in the CMV vaccine space. This puts all the more significance on the upcoming Triplex readouts. https://endpoints.news/modernas-cmv-vaccine-fails-phase-3-study-company-to-halt-most-development/?u=4562bd47-74cd-4c9f-9e0c-123b64557ebe&s=email&c=79153abc-da9759b9-4e537c38&utm_medium=email&utm_campaign=2316%20-%20Is%20neurology%20the%20hottest%20target%20for%20dealmaking%20Plus%20Mikael%20Dolstens%20new%20startup%20Basic&utm_content=2316%20-%20Is%20neurology%20the%20hottest%20target%20for%20dealmaking%20Plus%20Mikael%20Dolstens%20new%20startup%20Basic+CID_d55d83919f099059ced9c189f68f53e6&utm_source=ENDPOINTS%20emails&utm_term=Modernas%20CMV%20vaccine%20fails%20Phase%203%20study%20ending%20long-shot%20prevention%20effort

0 · Reply

Waters59 Oct. 23 at 1:51 PM

$FBIO Come on ride that train...!!! 🚀

0 · Reply

FinSUN Oct. 23 at 8:04 AM

$XBP Not to gloat, but I would like to point out to the scammer and offensive account @Breakoutstockmoves , that while he has been promoting this Chada's $XELA 2.0 scam and offend in the meantime, I have been realizing a 100% on $INTC and another one on $FBIO, all in 2 months timeframe. Always eager to compete with fraudsters, scammers, manipulators and stuffed shirts. The game is now open with other fraudsters in other tickers. Making money while exposing and destroying fraudsters is priceless.

1 · Reply

LiquidThetaLEAPS Oct. 23 at 4:41 AM

LiquidTheta® LEAPS LIVE Actionable Alert Asset: $FBIO Current Share Price: $2.54 Contracts: $FBIO April 17, 2026 $5 Calls Scale in: $0.21- $0.26 Scale out: $0.33-$0.43 Can Easily Capture: 60% ROI Blended DTE: 177 Days | Join Elites here: https://liquidtheta.com/options

0 · Reply

braves1983 Oct. 22 at 9:14 PM

$FBIO back to $2 I see

0 · Reply

Market Cap	74.98M
Revenue (ttm)	57.68M
Net Income (ttm)	-46.00M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-79.75%
Debt to Equity Ratio	1.44

Volume	366,100
Avg Vol	1,229,434
Day's Range	N/A - N/A
Shares Out	29.76M
Stochastic %K	3%
Beta	1.75
Analysts	Strong Sell
Price Target	$10.50